BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 34355541)

  • 1. The associations of CNR1 SNPs and haplotypes with vulnerability and treatment response phenotypes in Han Chinese with major depressive disorder: A case-control association study.
    Yang C; Nolte IM; Ma Y; An X; Bosker FJ; Li J
    Mol Genet Genomic Med; 2021 Sep; 9(9):e1752. PubMed ID: 34355541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of association of FKBP5 SNPs and haplotypes with susceptibility and treatment response phenotypes in Han Chinese with major depressive disorder: A pilot case-control study (STROBE).
    Yang C; Li S; Ma Y; Chen B; Li M; Bosker FJ; Li J; Nolte IM
    Medicine (Baltimore); 2021 Sep; 100(36):e26983. PubMed ID: 34516490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case-control association study.
    Kocabas NA; Faghel C; Barreto M; Kasper S; Linotte S; Mendlewicz J; Noro M; Oswald P; Souery D; Zohar J; Massat I
    Int Clin Psychopharmacol; 2010 Jul; 25(4):218-27. PubMed ID: 20531207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening genetic variability at the CNR1 gene in both major depression etiology and clinical response to citalopram treatment.
    Mitjans M; Serretti A; Fabbri C; Gastó C; Catalán R; Fañanás L; Arias B
    Psychopharmacology (Berl); 2013 Jun; 227(3):509-19. PubMed ID: 23407780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabinoid receptor 1 gene is associated with alcohol dependence.
    Marcos M; Pastor I; de la Calle C; Barrio-Real L; Laso FJ; González-Sarmiento R
    Alcohol Clin Exp Res; 2012 Feb; 36(2):267-71. PubMed ID: 22085192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Further evidence for association of polymorphisms in the CNR1 gene with cocaine addiction: confirmation in an independent sample and meta-analysis.
    Clarke TK; Bloch PJ; Ambrose-Lanci LM; Ferraro TN; Berrettini WH; Kampman KM; Dackis CA; Pettinati HM; O'Brien CP; Oslin DW; Lohoff FW
    Addict Biol; 2013 Jul; 18(4):702-8. PubMed ID: 21790903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain-derived neurotrophic factor gene polymorphisms: influence on treatment response phenotypes of major depressive disorder.
    Kocabas NA; Antonijevic I; Faghel C; Forray C; Kasper S; Lecrubier Y; Linotte S; Massat I; Mendlewicz J; Noro M; Montgomery S; Oswald P; Snyder L; Zohar J; Souery D
    Int Clin Psychopharmacol; 2011 Jan; 26(1):1-10. PubMed ID: 21188787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CNR1 gene is associated with high neuroticism and low agreeableness and interacts with recent negative life events to predict current depressive symptoms.
    Juhasz G; Chase D; Pegg E; Downey D; Toth ZG; Stones K; Platt H; Mekli K; Payton A; Elliott R; Anderson IM; Deakin JF
    Neuropsychopharmacology; 2009 Jul; 34(8):2019-27. PubMed ID: 19242408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of the potassium channel gene KCNK2 in major depressive disorder.
    Congiu C; Minelli A; Bonvicini C; Bortolomasi M; Sartori R; Maj C; Scassellati C; Maina G; Trabucchi L; Segala M; Gennarelli M
    Psychiatry Res; 2015 Feb; 225(3):489-92. PubMed ID: 25535009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association analysis for corticotropin releasing hormone polymorphisms with the risk of major depressive disorder and the response to antidepressants.
    Chang HS; Won E; Lee HY; Ham BJ; Lee MS
    Behav Brain Res; 2015 Oct; 292():116-24. PubMed ID: 26055202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for association between polymorphisms in the cannabinoid receptor 1 (CNR1) gene and cannabis dependence.
    Agrawal A; Wetherill L; Dick DM; Xuei X; Hinrichs A; Hesselbrock V; Kramer J; Nurnberger JI; Schuckit M; Bierut LJ; Edenberg HJ; Foroud T
    Am J Med Genet B Neuropsychiatr Genet; 2009 Jul; 150B(5):736-40. PubMed ID: 19016476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of BCL2 gene in major depression susceptibility and antidepressant treatment outcome.
    Zhang C; Wu Z; Hong W; Wang Z; Peng D; Chen J; Yuan C; Yu S; Xu L; Fang Y
    J Affect Disord; 2014 Feb; 155():288-94. PubMed ID: 24321200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequence variations of ABCB1, SLC6A2, SLC6A3, SLC6A4, CREB1, CRHR1 and NTRK2: association with major depression and antidepressant response in Mexican-Americans.
    Dong C; Wong ML; Licinio J
    Mol Psychiatry; 2009 Dec; 14(12):1105-18. PubMed ID: 19844206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GTP cyclohydrolase 1 gene haplotypes as predictors of SSRI response in Japanese patients with major depressive disorder.
    Kishi T; Ichinose H; Yoshimura R; Fukuo Y; Kitajima T; Inada T; Kunugi H; Kato T; Yoshikawa T; Ujike H; Musso GM; Umene-Nakano W; Nakamura J; Ozaki N; Iwata N
    J Affect Disord; 2012 Dec; 142(1-3):315-22. PubMed ID: 22770721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction between two independent CNR1 variants increases risk for cocaine dependence in European Americans: a replication study in family-based sample and population-based sample.
    Zuo L; Kranzler HR; Luo X; Yang BZ; Weiss R; Brady K; Poling J; Farrer L; Gelernter J
    Neuropsychopharmacology; 2009 May; 34(6):1504-13. PubMed ID: 19052543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabinoid receptor 1 (CNR1) gene: impact on antidepressant treatment response and emotion processing in major depression.
    Domschke K; Dannlowski U; Ohrmann P; Lawford B; Bauer J; Kugel H; Heindel W; Young R; Morris P; Arolt V; Deckert J; Suslow T; Baune BT
    Eur Neuropsychopharmacol; 2008 Oct; 18(10):751-9. PubMed ID: 18579347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Harm avoidance involved in mediating the association between nerve growth factor (NGF) gene polymorphisms and antidepressant efficacy in patients with major depressive disorder.
    Yeh YW; Kuo SC; Chen CY; Liang CS; Ho PS; Yen CH; Chen TY; Shyu JF; Wan FJ; Lu RB; Huang SY
    J Affect Disord; 2015 Sep; 183():187-94. PubMed ID: 26021968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations between polymorphisms in the cannabinoid receptor 1 gene, cognitive impairments and tardive dyskinesia in a Chinese population with schizophrenia.
    Lu C; Li S; Li Y; Zhang X; Chi J; Jiang Q; Ma Y; Shi X; Wang L; Li J
    Brain Res; 2023 Dec; 1821():148579. PubMed ID: 37739333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of cannabinoid receptor genes (
    Peiró AM; García-Gutiérrez MS; Planelles B; Femenía T; Mingote C; Jiménez-Treviño L; Martínez-Barrondo S; García-Portilla MP; Saiz PA; Bobes J; Manzanares J
    Anxiety Stress Coping; 2020 May; 33(3):256-265. PubMed ID: 32114795
    [No Abstract]   [Full Text] [Related]  

  • 20. Novel sequence variations in the brain-derived neurotrophic factor gene and association with major depression and antidepressant treatment response.
    Licinio J; Dong C; Wong ML
    Arch Gen Psychiatry; 2009 May; 66(5):488-97. PubMed ID: 19414708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.